Spine News and Research

RSS

Functional MRI illuminates brain networks activated by motion

An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead to uncontrolled twisting and turning in awkward, sometimes painful postures.

14 Nov 2011

SANUWAVE Health third quarter revenues decrease 42% to $161,678

SANUWAVE Health, Inc. today reported financial results for the three and nine months ended September 30, 2011.

14 Nov 2011

Health supplement hope for child muscle disease

A health supplement used by bodybuilders could be the key to treating a life-threatening muscular dystrophy affecting hundreds of Australian children, new research shows.

14 Nov 2011

Kanghui third quarter total net revenue increases 26.9% to RMB80.7M

China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the third quarter of 2011.

10 Nov 2011

Celgene to initiate apremilast Phase III placebo-controlled trial for ankylosing spondylitis

Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced data from a Phase II study of apremilast, its investigational oral immunomodulatory compound, in patients with ankylosing spondylitis (AS) were presented at the American College of Rheumatology Scientific Meeting in Chicago, IL.

9 Nov 2011

BioMimetic Therapeutics reports third quarter total revenues of $0.4M

BioMimetic Therapeutics, Inc., a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today reported its financial results as of and for the three and nine months ended September 30, 2011.

9 Nov 2011

Five-year results from Abbott's HUMIRA ATLAS study on ankylosing spondylitis

Abbott today announced five-year results from the open-label extension of the ATLAS study, which evaluated the long-term impact of treatment with HUMIRA (adalimumab) on disease activity, including spinal mobility in patients with active ankylosing spondylitis.

8 Nov 2011

Brain bypass still plays a critical role in management of selected neurovascular disorders

A microsurgical procedure that has lost some ground to advances in endovascular therapy still plays a critical role in the management of selected neurovascular disorders, according to a University Hospitals Case Medical Center neurosurgeon who performs the procedure.

8 Nov 2011

Low-grade inflammatory processes drive development of osteoarthritis

In a study to be published online Nov. 6 in Nature Medicine, investigators at the Stanford University School of Medicine have shown that the development of osteoarthritis is in great part driven by low-grade inflammatory processes.

8 Nov 2011

Study finds spinal bleeding in young children with abusive head trauma

A new study found that spinal bleeding is found often in young children who are victims of abusive trauma. The findings support performing complete spine imaging for children undergoing brain magnetic resonance imaging (MRI) for moderate or severe traumatic brain injury and suggest a pathway for distinguishing between abusive and accidental injury.

8 Nov 2011

Abbott announces results from HUMIRA Phase 3 study on axSpA

Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.

7 Nov 2011

Potential predictors of spinal damage progression in people with spondyloarthritis

The presence of syndesmophytes (bony growths in the spine), acute phase reactants (proteins that are released into the blood in response to inflammation), and smoking status can all serve as predictors for the progression of structural damage in the spine in people with spondyloarthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

7 Nov 2011

Metier obtains $9 million verdict against Campbell County Memorial Hospital

Tom Metier of Metier Law Firm, LLC, of Cheyenne, Wyoming and Fort Colllins, Colorado, obtained a $9 million verdict for plaintiffs Louis and Rebecca Prager against Campbell County Memorial Hospital and Brian Cullison, M.D. for medical negligence.

5 Nov 2011

K2M adds two additions to family of ALEUTIAN Interbody Systems for lumbar applications

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today debuted two additions to the family of ALEUTIAN Interbody Systems at the 2011 North American Spine Society Annual Meeting in Chicago.

5 Nov 2011

Study demonstrates need for new testing standards, greater focus on youth helmets

Old-fashioned "leatherhead" football helmets from the early 1900s are often as effective as - and sometimes better than - modern football helmets at protecting against injuries during routine, game-like collisions, according to Cleveland Clinic researchers.

5 Nov 2011

Novel technique could help avoid wrong-level thoracic spine surgery

It does not happen often, but nearly 50 percent of spine surgeons perform surgery on the wrong level of the spine sometime during their career.

5 Nov 2011

Bluewater Surgical signs distribution agreement with SurgLine

China Nuvo Solar Energy, Inc. today announced that SurgLine, Inc. has signed an agreement with Bluewater Surgical, Inc. to a western distributorship. Bluewater surgical plans to offer SurgLine products for spine surgery, sports medicine, trauma surgery and more to acute care hospitals and physician owned surgery centers as an alternative to the high priced medical device providers in the marketplace.

5 Nov 2011